Cybin (HELP) Other Non-Current Liabilities (2021 - 2025)

Cybin (HELP) posted quarterly Other Non-Current Liabilities of $19.2 million for Q3 2025, down 5.11% year-on-year from $20.2 million in Q3 2024, and little changed on a QoQ basis from $19.2 million in Q2 2025.

Cybin (HELP) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

Cybin (HELP) has reported Other Non-Current Liabilities for 5 consecutive years, with $19.2 million the latest figure, recorded in Q3 2025.

  • Quarterly Other Non-Current Liabilities fell 5.11% year-over-year to $19.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19.2 million (down 5.11% YoY) and the FY2024 annual result came in at $19.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities held at $19.2 million in Q3 2025 per HELP's latest filing, from $19.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for HELP reached as high as $23.6 million in Q4 2023 and fell as low as $8.0 million in Q4 2022.
  • A 5-year average of $14.1 million and a median of $10.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities soared 194.72% — and 2024, when it declined 16.33%.
  • Year by year, Other Non-Current Liabilities stood at $9.2 million in 2021, then decreased by 13.0% to $8.0 million in 2022, then surged by 194.72% to $23.6 million in 2023, then retreated by 16.33% to $19.8 million in 2024, then fell by 2.83% to $19.2 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $19.2 million, $19.2 million, and $19.8 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cybin 28.04 Mn 28.04 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 19.19 Mn
Jun 30, 2025 19.19 Mn
Dec 31, 2024 19.75 Mn
Sep 30, 2024 20.23 Mn
Jun 30, 2024 18.75 Mn
Mar 31, 2024 19.03 Mn
Dec 31, 2023 23.61 Mn
Sep 30, 2023 10.68 Mn
Jun 30, 2023 8.09 Mn
Dec 31, 2022 8.01 Mn
Sep 30, 2022 8.64 Mn
Dec 31, 2021 9.21 Mn
Sep 30, 2021 9.29 Mn
Jun 30, 2021 9.13 Mn
Mar 31, 2021 8.82 Mn